News Sentiment

BEAT sentiment intelligence

Heartbeam Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 0.56 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-7.6% over one week, -26.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Mercantile Bank (NASDAQ:MBWM) Surges on Q2 Earnings Beat, Highlighting Quality Stock Performance

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -7.6% Price reacting lower
Trend fit Trend inactive -26.4% over four weeks
Fair value -69.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 20
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 7
TradingKey 7
Business Wire 5
TradingView 4
Market source 4
ChartMill 2
Investing.com 2
NewMediaWire 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 11
Analyst action 2
Regulatory and legal 2
Balance sheet 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40
GuruFocus Direct company coverage

BEAT Initiated Coverage by Maxim Group -- Price Target Announced at $2.00

Maxim Group has initiated coverage on HeartBeam (BEAT) with a 'Buy' rating and a price target of $2.00, signaling confidence in the company's growth potential. This comes despite HeartBeam's low GF Score™ of 26/100, which indicates weaknesses in profitability and growth, but a st

Tone
Positive 73/100
Event
Analyst action
Published
14 Jul 2026 17:10
Source
GuruFocus
Investing.com Direct company coverage

HeartBeam receives patent for multi-modal cardiac sensing device

HeartBeam Inc. has been granted a U.S. patent for a multi-modal cardiac sensing device that integrates acoustic sensing and thoracic impedance measurements into its credit card-sized ECG device. This new technology aims to improve the management of heart failure by detecting hear

Tone
Positive 63/100
Event
Balance sheet
Published
14 Jul 2026 12:10
Source
Investing.com
timothysykes.com Direct company coverage

Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live quotes and charts for Heartbeam Inc. (BEAT) stock, which is currently trading at $0.6369 with a slight decrease. It notes that there are no analyst ratings or earnings information currently available for the company. The rest of the page primarily consists

Tone
Neutral 50/100
Event
Earnings
Published
09 Jul 2026 23:10
Source
timothysykes.com
The Globe and Mail Direct company coverage

HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

HeartBeam (NASDAQ: BEAT) has completed patient enrollment ahead of schedule for its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection. The study enrolled 120 patients and data analysis is now underway, with results expected to be presented at

Tone
Positive 71/100
Event
Earnings
Published
05 Jul 2026 00:41
Source
The Globe and Mail
Stock Titan Direct company coverage

Nasdaq warns HeartBeam (NASDAQ: BEAT) over $1 minimum bid price rule

HeartBeam, Inc. (NASDAQ: BEAT) has received a notice from Nasdaq stating that its common stock is not in compliance with the exchange's minimum $1.00 bid price requirement, having traded below this level for 30 consecutive business days. The company has 180 calendar days, until D

Tone
Negative 36/100
Event
Market update
Published
02 Jul 2026 20:40
Source
Stock Titan
TradingView Direct company coverage

HeartBeam Disclosed Failure to Satisfy a Continued Listing Rule or Standard

HeartBeam (BEAT) received a Nasdaq deficiency notice on June 30, 2026, for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 days, until December 28, 2026, to regain compliance, with a possibility of an extension. This informat

Tone
Negative 14/100
Event
Market update
Published
02 Jul 2026 20:40
Source
TradingView
TradingView Direct company coverage

Heartbeam, Inc. Warrant 2021-31.10.26 on HeartBeam Financial Disclosures & SEC Filings

This page provides access to Heartbeam, Inc.'s SEC filings and other important company documents, such as Forms 10-K, 10-Q, and 8-K. Investors can review these disclosures to evaluate the company's financial performance and operational updates. The documents span from 2021 to 202

Tone
Positive 67/100
Event
Market update
Published
02 Jul 2026 19:11
Source
TradingView
Market source Direct company coverage

HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

HeartBeam (NASDAQ: BEAT) is developing technologies to expand the use of ECG data beyond hospital settings, focusing on timely and actionable insights for cardiac care. Their proprietary, FDA-cleared HeartBeam System is a portable, cable-free ECG system that synthesizes a 12-lead

Tone
Positive 74/100
Event
Market update
Published
01 Jul 2026 17:39
Source
Market source
Investing.com Direct company coverage

HeartBeam completes enrollment in heart attack detection study

HeartBeam, Inc. has completed patient enrollment in its ALIGN-ACS pilot study, evaluating its HeartBeam System for heart attack detection ahead of schedule. The study involved 120 patients in Serbia and its findings will inform a planned pivotal study in the U.S. and support a fu

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 21:39
Source
Investing.com
NewMediaWire Direct company coverage

HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

HeartBeam (NASDAQ: BEAT) has successfully completed patient enrollment for its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection, ahead of its scheduled timeline. The study included 120 patients at two sites in Serbia, utilizing both standard

Tone
Positive 71/100
Event
Market update
Published
30 Jun 2026 21:10
Source
NewMediaWire
MarketBeat Direct company coverage

HeartBeam (BEAT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $BEAT

This article details the FDA approval process and regulatory events for HeartBeam (BEAT), focusing on two key therapies: ALIGN-ACS for heart attack detection and the HeartBeam system for comprehensive arrhythmia assessment. It highlights the recent completion of patient enrollmen

Tone
Positive 72/100
Event
Regulatory and legal
Published
30 Jun 2026 17:09
Source
MarketBeat
Business Wire Direct company coverage

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

HeartBeam, Inc. has completed patient enrollment in its ALIGN-ACS pilot study for heart attack detection ahead of schedule, evaluating its 3D ECG technology. Data analysis is currently underway, with full results expected to be presented at a cardiology conference later this year

Tone
Positive 74/100
Event
Earnings
Published
30 Jun 2026 11:09
Source
Business Wire
Market source Direct company coverage

HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp

HeartBeam (BEAT) recently saw its fair value estimate cut by analysts from $5.08 to $3.83 per share, primarily due to recent equity offerings causing dilution and a slower-than-expected revenue ramp. Despite these reductions, some analysts maintain bullish ratings, citing a solid

Tone
Negative 30/100
Event
Earnings
Published
27 Jun 2026 12:08
Source
Market source
TradingView Direct company coverage

HeartBeam, Inc. Actuals & Estimates (NASDAQ:BEAT)

This article provides an in-depth financial overview of HeartBeam, Inc. (NASDAQ:BEAT), including its current stock price, historical performance, analyst forecasts, and key financial metrics like market capitalization, earnings, and revenue. It highlights a significant decrease i

Tone
Negative 34/100
Event
Earnings
Published
25 Jun 2026 16:40
Source
TradingView
Market source Direct company coverage

HeartBeam (BEAT) Reorganizes to Accelerate Global Commercialization Strategy

HeartBeam (NASDAQ: BEAT) announced a strategic reorganization to accelerate its global commercialization strategy for its cardiac monitoring technology. This includes streamlining decision-making, improving accountability, and reducing costs, with founder Branislav Vajdic, Ph.D.,

Tone
Positive 70/100
Event
Market update
Published
25 Jun 2026 03:09
Source
Market source
Stock Titan Direct company coverage

Leadership shakeup as HeartBeam (NASDAQ: BEAT) reorganizes for global ECG push

HeartBeam, Inc. (NASDAQ: BEAT) announced a strategic reorganization to accelerate global adoption of its ambulatory ECG signal platform and improve capital efficiency. CEO Robert P. Eno will depart on June 30, 2026, with Founder and President Branislav Vajdic, Ph.D., taking over

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 21:11
Source
Stock Titan
Business Wire Direct company coverage

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

HeartBeam, Inc. has announced a strategic reorganization to accelerate the global adoption of its ambulatory ECG signal platform, moving beyond direct medical device sales to license its 3D ECG technology to established partners. The company aims to broaden its market reach, focu

Tone
Positive 74/100
Event
Market update
Published
24 Jun 2026 20:11
Source
Business Wire
TradingView Direct company coverage

HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

HeartBeam (NASDAQ: BEAT) has initiated a pilot study to evaluate its proprietary on-demand 12-lead ECG patch for detecting coronary artery disease and ischemia. This technology aims to provide clinical-grade insights over extended periods, an advancement not previously possible w

Tone
Positive 72/100
Event
Market update
Published
23 Jun 2026 17:42
Source
TradingView
Market source Direct company coverage

HeartBeam (BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

HeartBeam (NASDAQ: BEAT) has initiated a pilot study to evaluate its proprietary on-demand 12-lead ECG patch for detecting coronary artery disease and ischemia. This study aims to address the urgent and widespread health threat of coronary artery disease by providing a faster and

Tone
Positive 72/100
Event
Market update
Published
23 Jun 2026 14:15
Source
Market source
Stock Titan Direct company coverage

[8-K] HeartBeam, Inc. Reports Material Event

HeartBeam, Inc. announced new compensation arrangements for its President, Founder, and Director, Dr. Branislav Vajdic, including a performance-based restricted stock unit (PRSU) award and a Transaction Bonus Agreement. The PRSUs, totaling 2,800,000 units, are contingent on achie

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 05:39
Source
Stock Titan
Quiver Quantitative Direct company coverage

BEATW | Heartbeam, Inc. Warrant Insider Trading

This Quiver Quantitative page provides an overview of Heartbeam, Inc. Warrant (BEATW) focusing on insider trading activity, institutional holdings, analyst ratings, and company financials. It indicates no recent insider trading for this specific ticker and lists institutional own

Tone
Neutral 50/100
Event
Analyst action
Published
21 Jun 2026 21:09
Source
Quiver Quantitative
TradingKey Direct company coverage

Heartbeam Inc (BEATW) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Heartbeam Inc (BEATW)'s dividend and stock split history. It states that no dividend data or stock split data is available for the company. The article also includes current stock price information and links to various financial news and analy

Tone
Neutral 50/100
Event
Capital return
Published
19 Jun 2026 16:10
Source
TradingKey
TradingKey Direct company coverage

Heartbeam Inc (BEATW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey attempts to provide a revenue breakdown for Heartbeam Inc (BEATW), including business segments, regional revenue, and profit contribution. However, the article states that relevant data for these categories have not been disclosed by the company yet.

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 09:11
Source
TradingKey
Stock Titan Direct company coverage

HeartBeam (NASDAQ: BEAT) seeks approval for 3M-share equity plan increase at 2026 meeting

HeartBeam, Inc. (NASDAQ: BEAT) is seeking shareholder approval to amend its 2022 Equity Incentive Plan to increase the number of authorized shares by 3,000,000, bringing the total capacity to 14,900,000 shares. This proposal, discussed in a definitive proxy statement for the July

Tone
Neutral 50/100
Event
Regulatory and legal
Published
18 Jun 2026 20:46
Source
Stock Titan
TradingKey Direct company coverage

Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Heartbeam Inc (BEAT), focusing on support, resistance, indicators, and moving averages. While relevant data for support and resistance have not been disclosed, the analysis covers various technical indicators like MACD, RSI, and KDJ,

Tone
Negative 40/100
Event
Market update
Published
18 Jun 2026 14:46
Source
TradingKey